Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOCETIRIZINE DIHYDROCHLORIDE, with a corresponding US DMF Number 22286.
Remarkably, this DMF maintains an Active status since its submission on December 15, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2017, and payment made on April 27, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II